The new clinical arena represents hybrid chains. Such engineered compounds merge segments of various amino acid families, allowing the development of unique therapeutic functions. This strategy provides a exciting https://chimerapeptides287007.polarisnewsblog.com/835135/chimera-peptides-a-novel-therapeutic-frontier